I am a third-year clinical fellow in Hematology & Medical Oncology at the Boston Medical Center (BMC) and a Clinical Instructor at the Boston University Chobanian & Avedisian School of Medicine (BUSM). Under the clinical and research mentorship of Dr. J Mark Sloan, I have developed an interest in dedicating to the clinical care of patients with virally-mediated (HTLV-, EBV-, and HIV- associated) lymphomas. My clinical research activities are focused on improving access to clinical trials and identifying tolerable and effective regimens for patients with virally-mediated lymphomas.
Prior to fellowship, I have spent the entirety of my clinical training in safety-net settings. After internal medicine residency at SUNY Downstate Medical Center/Kings County Hospital Center, I completed a chief residency year. I focused my chief residency year on improving access to outpatient cancer screening for safety-net patients and establishing a mentoring program for trainees.
Diversity, Equity, Inclusion and Accessibility
I deeply believe in our institutional mission to provide "exceptional care beyond exception." I am part of a dedicated team of healthcare trainees, professional, researchers, students and staff from different countries and various regions of the US and serve a similarly diverse patient population. The culture of our section is defined by the unique perspectives that each of us brings with us. As both a large academic medical center and safety-net hospital serving the communities of Boston and its surroundings, Boston Medical Center offers the unique opportunity to engage in cutting edge research and gain real-world clinical experience by caring for local and underserved populations. Our multilingual team is committed to promoting cultural competency, equity and inclusion in science, medicine and healthcare. We strive to maintain a workforce that is as diverse as the communities we serve and aim to create a safe space for our members to learn, grow and succeed in their life goals. Acknowledging that we all have a role to play, I am dedicated to welcoming and celebrating individuals of all races. ethnicities, social backgrounds, religion, gender, sex, age, ability, sexual orientation, veteran status, and national origin. I seek to promote DEIA principles by increasing clinical trial participation of our safety-net population and to better learn how to address sociocultural barriers to meet the diverse healthcare needs of our patients.
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Saggi SJ, Nath S, Culas R, Chittalae S, Burza A, Srinivasan M, Abdul R, Silver B, Lora A, Ibtida I, Chokshi T, Capric V, Mohamed A, Worah S, OuYang J, Geraghty P, Gruessner A, Salifu MO. Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis. Clin Med Insights Circ Respir Pulm Med. 2020; 14:1179548420980699. PMID: 33402859; PMCID: PMC7745550; DOI: 10.1177/1179548420980699;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
